Niva Bupa Health Insurance Company Limited – Investor Presentation Summary

Key Operational Highlights

  • Gross Written Premium (GWP) with 1/n accounting reached ₹2,150.0 crore in Q1 FY2027, a 31.7% year-on-year (YoY) increase from ₹1,631.9 crore in Q1 FY2026.
  • Retail Health GWP with 1/n accounting was ₹1,607.1 crore, a 47.1% YoY growth from ₹1,092.4 crore.
  • The renewal rate for Retail Health Indemnity products (by value) improved to 95.8% in Q1 FY2027 from 92.5% in Q1 FY2026.
  • The average ticket size per policy in the Agency Channel increased to ₹30,244 from ₹24,889 YoY.
  • GWP contribution of new retail health indemnity policies with a sum insured >= ₹1 million rose to 92.7% from 81.7% YoY.
  • The company expanded its distribution network, adding 13,000 individual agents (total 251,834), 13 Banca & Other Corporate Agents (total 134), and 10 brokers (total 603) in the quarter.
  • Employee count increased by 392 to 10,583.
  • Key drivers of operational performance: Strong growth in retail health segment, improved renewal rates, higher average ticket sizes, and expansion of distribution network.

Segment-wise Performance

  • The presentation focuses on the consolidated performance of the health insurance business. A detailed segment-wise breakdown of revenues and margins is not provided.

Financial Highlights

  • Revenue (Insurance Revenue as per Ind AS): ₹5,274.6 crore for FY2026; Not specified for Q1 FY2027.
  • Profit After Tax (PAT): ₹137.8 crore in Q1 FY2027, a 92.9% YoY increase from ₹71.4 crore in Q1 FY2026.
  • Combined Insurance Service Ratio (CISR): 100.2% in Q1 FY2027, an improvement from 103.2% in Q1 FY2026.
  • Claims Ratio: 63.0% in Q1 FY2027, improved from 66.8% in Q1 FY2026.
  • Expense Ratio: 37.2% in Q1 FY2027, compared to 36.4% in Q1 FY2026.
  • Expense of Management as % of GWP: 35.2% in Q1 FY2027, improved from 38.0% in Q1 FY2026.
  • Drivers of financial performance: Higher premium growth, improved claims ratio, and disciplined expense management.
  • Comparison to market estimates: Not provided.
  • Key Risks: Not explicitly disclosed in the presentation.

Geographical Revenue Split

  • Domestic vs Export/Regional Revenue: Not specified.

Balance Sheet Snapshot

  • Solvency Ratio: 2.25x as of Q1 FY2027, compared to 2.86x in Q1 FY2026 and 2.49x for FY2026.
  • Financial Health Insights: Not provided in detail beyond the solvency ratio.

Capex & Cash Flow Health

  • Capital Expenditure: Not specified.
  • Free Cash Flow: Not specified.
  • Operating Cash Flow: Not specified.
  • Net Debt Movement: Not applicable as the company is an insurance provider; focus is on investment assets.
  • Investment Rationale: The company maintains a robust approach to investment management. Assets Under Management (AUM) grew to ₹13,724 crore as of Q1 FY2027 from ₹11,126 crore in Q1 FY2026. 97.9% of the debt security portfolio was rated ‘AA’ and above.

Strategic & R&D Initiatives

  • Investments in Innovation: The company emphasizes a technology and analytics-driven business model. Key digital metrics for Q1 FY2027 include: 100.0% of new policies applied via website and mobile apps, 97.5% digital payments, 48.2% retail policies auto-decisioned, 93.1% claims submitted digitally, 38.4% cashless claims auto-adjudicated, 89.2% renewals completed without human intervention, and 86.5% cashless claims processed in <30 mins.
  • Strategic Rationale: To build a granular, growth-oriented, and profitable health insurance franchise by being the health partner of choice, leveraging multi-channel distribution, and embedding technology and analytics into operations.

Industry Trends & Business Environment

  • Macro/Industry Trends: The Indian economy's GDP growth was 7.7% in FY2026. The General Insurance sector achieved 10.9% growth in Gross Direct Premium, accelerating from 8.8% in Q1 FY2026. The Health segment (including PA) demonstrated 22.4% growth, up from 10.3% in Q1 FY2026.
  • Impact on Company: The company outperformed the broader health insurance market growth, achieving 31.7% GWP growth.

Management Commentary & Growth Outlook

  • Strategic Outlook: Management commentary highlights the transition to Indian Accounting Standards (Ind AS) as a significant milestone enhancing financial transparency. The company was ranked 41st among India's Top 100 Great Places to Work 2026. The Weighted Episodal Net Promoter Score (NPS) improved to 62 in Q1 FY2027 from 57 in Q1 FY2026.
  • FY Guidance: Not explicitly provided.
  • Market Share Targets: The company's Q1 FY2027 Retail Health market share is reported at 11.1%, improving from 10.0% in Q1 FY2026.
  • Risks and Opportunities: Not explicitly highlighted beyond the standard disclaimer on forward-looking statements.